Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ANDRX (ADRX) -- Ignore unavailable to you. Want to Upgrade?

To: Jolie Renee who wrote (57)	4/21/1998 7:55:00 AM
From: Emec	Respond to of 127

Jolie, I believe you are in for a great ride on ADRX.

To: Jolie Renee who wrote (57)	4/21/1998 8:22:00 AM
From: PAUL ROBERT ST. ONGE	Respond to of 127

Do not know. In general these message boards are dead. You have short term players, day traders, who will say anything to get a stock to move either way. I found very little intelligent life, and only continue to post messages for those who have genuine questions or who want to really learn about the company. Andrx looks like it will continue to head higher, but a breathier is possible here, I would then look for higher prices.

To: Jolie Renee who wrote (57)	4/21/1998 8:55:00 PM
From: PAUL ROBERT ST. ONGE	Read Replies (2) \| Respond to of 127

If Andrx has filed for an ANDA for Prilosec, you can bet your bottom dollar that a NDA will follow-it! They stated in November I believe that they intend to file for a NDA version of Prilosec! Well with their generic formulation complete, you can bet that an NDA will follow, as most of the science was already done in formulating the generic. Second, NDA's typically are approved approx. in one year! The litigation if anything is different or non-existent, and the approval process is quicker. This would double or triple the revenues of the company, use a thirty times multiple (current model) and this stock will likely double or better. Hang in there, ride out this bumpy ride, then it's straight up!